Robert Wood Johnson University Hospital deploys two Tru-D SmartUVC devices
Initiative to reduce Clostridium difficile infections at Robert Wood Johnson University Hospital (RWHUH) now includes 2 Tru-D SmartUVC high-tech UV germicidal decontamination devices to used at terminal room cleaning.
As part of a multi-faceted approach to prevent the incidence of hospital-acquired Clostridium difficile infection, RWJUH again has take the lead by introducing Tru-D® SmartUVC™ touchless light decontamination. Hospitals across the US have seen an increased frequency of C. difficile colitis cases, replacing MRSA as the number one cause of Healthcare Acquired Infection (HAI) in many states.
This technological advancement introduced to the area through RWJUH places it on the leading edge of medical care in New Jersey. Mike Antoniades, VP of Operations challenges his staff to deliver the highest levels of healthcare to the community. “We looked at a number of technologies. Tru-D’s SmartUVC™ disinfection will insure ongoing improvements in patient safety and quality of care” said Antonididis. “Environmental disinfection can reduce patients’ risk of developing healthcare-acquired infections” stated Joseph Stokes, Director Environmental/ Host Services. “At Crothall we take great pride in introducing technology like the Tru-D SmartUVC™ device to make RWJUH a safer place”, added Stokes.
Tru-D decontamination was implemented early last year and now RWJUH has acquired another Tru-D SmartUVC™ device to expand their capacity for enhanced disinfection of patient areas. These mobile automated cleaning systems use SmartUVCTM UV light to disrupt the DNA of bacteria, virus and spores and render them harmless. Clinical research has shown that Tru-D’s patented Sensor360TM array automatically calculates and delivers the lethal UV dose required for each room, resulting in a 99 percent reduction of highly resistant C. diff spores. The automated system overcomes the human error with the manual dose calculations used by other systems, and missed disinfectant wiping in difficult-to-reach surfaces.
Routine room cleaning will be followed by disinfection of all surfaces with cleansing germicidal UVC energy, which kills even drug resistant bacterial and viral pathogens that may be airborne and on surfaces.
- The Tru-D system uses safe UVC light that does not pass through ordinary window glass, making it safe to use in routine hospital operations.
- The room is available for use immediately after the Tru-D disinfection cycle
- New patient protection protocols were developed for contact isolation patients, including changes in equipment that travels among patients. Guidance and education is provided to all staff.
Background on Clostridium difficile. Clostridium difficile infection, commonly called C. difficile or C.diff, causes severe diarrhea and is usually associated with antibiotic usage. It ranges in severity from asymptomatic to life threatening, particularly among the elderly. The rate of C.diff is estimated to be about 1% for patients overall, with higher rates for patients with longer hospitalizations. C.diff spores are both long-lived and resistant to most cleaning methods except for properly applied bleach solutions and accurately dosed UVC light decontamination.
Tru-D® Smart UVCTM is the only calibrated UV disinfection instrument that has undergone rigorous third party clinical testing on hundreds of contaminated hospital rooms under demanding, scientifically controlled conditions. SmartUVCTM is not based on calculated averages or estimates. It precisely measures reflected UVC emissions with its patented Sensor360TM array that scans the targeted space to automatically calculate the lethal UV dose required for each room. Performance is confirmed by independent scientific studies conducted by leading infection control authorities.
– See more at: http://www.tru-d.com/news/robert-wood-johnson-university-hospital-deploys-two-tru-d-smartuvc-devices-/#sthash.bSm4b8U5.dpuf